Skip to main content
Back
SMMNY logo

Siemens Healthineers AG

Data quality: 100%
Oversold
SMMNY
OTC Healthcare Medical - Devices
$21.24
$0.00 (0.00%)
Mkt Cap: 95.64B
Also listed as SEMHF OTC
Day Range
$21.13 $21.42
52-Week Range
$20.85 $28.92
Volume
24,924
50D / 200D Avg
$24.54 / $26.27
Prev Close
$21.24

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (631 peers)

Metric Stock Sector Median
P/E 47.3 0.2
P/B 4.5 3.0
ROE % 10.3 3.6
Net Margin % 9.2 3.8
Rev Growth 5Y % 5.2 9.9
D/E 0.8 0.2

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $1.88
$1.84 – $1.94
 30.83B 1
FY2029 $1.70
$1.66 – $1.75
 29.02B 1
FY2028 $1.51
$1.48 – $1.56
 27.16B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-05 $0.22 $0.23 +4.3%
2025-11-05 $0.40 $0.31 -22.9%
2025-07-30 $0.31 $0.29 -7.2%
2025-05-07 $0.31 $0.28 -8.7%
2025-02-06 $0.24 $0.34 +38.9%
2024-11-06 $0.38 $0.31 -19.2%
2024-07-31 $0.25 $0.26 +4.0%
2024-05-07 $0.26 $0.55 +111.5%

Dividend History

6 yr streak

Yield

0.02%

Payout Ratio

0.50%

Growth (3Y)

-1.63%

Growth (5Y)

2.12%

Ex-Date Payment Date Amount Yield
Feb 09, 2026 Feb 24, 2026 $0.37 1.51%
Feb 20, 2025 Mar 07, 2025 $0.52 1.80%
Apr 19, 2024 May 07, 2024 $0.54 1.99%
Feb 16, 2023 Mar 06, 2023 $0.54 2.03%
Feb 16, 2022 Mar 07, 2022 $0.55 1.75%
Feb 12, 2021 Mar 03, 2021 $0.58 1.97%
Feb 13, 2020 Mar 05, 2020 $0.47 2.16%
Feb 06, 2019 Feb 25, 2019 $0.45 2.22%

Key Takeaways

Revenue grew 5.19% annually over 5 years — modest growth
ROE of 10.26% — decent returns on equity
Generating 2.14B in free cash flow
P/E of 47.32 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.67%
Cash machine — converts 105.64% of earnings into free cash flow

Growth

Revenue Growth (5Y)
5.19%
Revenue (1Y)-1.48%
Earnings (1Y)4.07%
FCF Growth (3Y)48.28%

Quality

Return on Equity
10.26%
ROIC6.24%
Net Margin9.17%
Op. Margin14.70%

Safety

Debt / Equity
0.83
Current Ratio1.11
Interest Coverage8.08

Valuation

P/E Ratio
47.32
Forward P/E18.16
P/B Ratio4.51
EV/EBITDA34.33
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -1.48% Revenue Growth (3Y) 0.81%
Earnings Growth (1Y) 4.07% Earnings Growth (3Y) 15.73%
Revenue Growth (5Y) 5.19% Earnings Growth (5Y) 4.01%
Profitability
Revenue (TTM) 22.03B Net Income (TTM) 2.02B
ROE 10.26% ROA 3.88%
Gross Margin 38.63% Operating Margin 14.70%
Net Margin 9.17% Free Cash Flow (TTM) 2.14B
ROIC 6.24% FCF Growth (3Y) 48.28%
Safety
Debt / Equity 0.83 Current Ratio 1.11
Interest Coverage 8.08
Dividends
Dividend Yield 0.02% Payout Ratio 0.50%
Dividend Growth (3Y) -1.63% Dividend Growth (5Y) 2.12%
Consecutive Div Years 6 yrs
Valuation
P/E Ratio 47.32 Forward P/E 18.16
P/B Ratio 4.51 P/S Ratio 4.34
PEG Ratio 7.41 Forward PEG N/A
EV/EBITDA 34.33 Fwd EV/EBITDA 24.15
Forward P/S 3.95 Fwd Earnings Yield 5.51%
FCF Yield 2.23%
Market Cap 95.64B Enterprise Value 111.17B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 22.03B 22.36B 21.68B 21.71B 18.00B
Net Income 2.02B 1.94B 1.51B 2.04B 1.73B
EPS (Diluted) 0.90 0.87 0.67 0.91 0.78
Gross Profit 8.51B 8.47B 7.71B 8.14B 6.95B
Operating Income 3.24B 3.30B 2.44B 3.06B 2.78B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 52.13B 46.06B 46.68B 49.06B 41.93B
Total Liabilities 30.88B 27.81B 28.55B 29.20B 25.87B
Shareholders' Equity 21.20B 18.20B 18.08B 19.84B 16.04B
Total Debt 17.70B 16.21B 16.65B 16.65B 14.32B
Cash & Equivalents 2.18B 2.68B 1.64B 1.44B 1.32B
Current Assets 16.57B 14.44B 14.14B 13.38B 10.78B
Current Liabilities 14.86B 11.57B 13.44B 12.02B 10.11B